Literature DB >> 11243697

Chemokine receptor desensitization in tumor-bearing mice.

R A Kurt1, A Baher, K P Wisner, S Tackitt, W J Urba.   

Abstract

We found that the murine breast cancer cell line 4T1 constitutively produced several chemokines capable of recruiting T cells. Additionally, supernatants from the tumor cell line mediated chemotaxis of T cells in a pertussis toxin-sensitive manner, indicating that these chemokines were functional. However, we also found an impaired chemotactic ability of splenic T cells in mice bearing these same tumors. The receptors for RANTES, MCP-1, and SLC were desensitized. Thus, the impaired chemotactic ability of T cells in tumor-bearing mice may explain why tumors that secrete chemokines grow progressively in a host. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243697     DOI: 10.1006/cimm.2000.1754

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  16 in total

1.  Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.

Authors:  Stacey L Hembruff; Iman Jokar; Li Yang; Nikki Cheng
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.

Authors:  Jennifer L Owen; Michael F Criscitiello; Stephania Libreros; Ramon Garcia-Areas; Kathleen Guthrie; Marta Torroella-Kouri; Vijaya Iragavarapu-Charyulu
Journal:  Cell Immunol       Date:  2011-05-10       Impact factor: 4.868

3.  Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.

Authors:  Yi Ban; Junhua Mai; Xin Li; Marisa Mitchell-Flack; Tuo Zhang; Lixing Zhang; Lotfi Chouchane; Mauro Ferrari; Haifa Shen; Xiaojing Ma
Journal:  Cancer Res       Date:  2017-04-17       Impact factor: 12.701

4.  The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.

Authors:  Adit Ben-Baruch
Journal:  Cancer Microenviron       Date:  2011-12-22

5.  Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.

Authors:  Yu-Qing Liu; Ronnie-T Poon; Jeremy Hughes; Qin-Yu Li; Wan-Ching Yu; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

Review 6.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.

Authors:  Sally A DuPré; Doug Redelman; Kenneth W Hunter
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

Review 8.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

9.  Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination.

Authors:  Taylor H Schreiber; Vadim V Deyev; Joseph D Rosenblatt; Eckhard R Podack
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women.

Authors:  Jyh-Ming Liou; Jaw-Town Lin; Shih-Pei Huang; Chun-Ying Wu; Hsiu-Po Wang; Yi-Chia Lee; Han-Mo Chiu; Chia-Tung Shun; Ming-Tsan Lin; Ming-Shiang Wu
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.